Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) opera en el sector Healthcare, cotizado por última vez a $2.27 con una capitalización de mercado de 175576768. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 4 feb 2026Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) Resumen de Asistencia Médica y Tuberías
Accendra Health, Inc. (ACH) offers comprehensive healthcare solutions, providing medical supplies and services to providers and patients. With a focus on supply chain efficiency and patient-direct care, ACH aims to optimize healthcare delivery, despite current profitability challenges and a competitive landscape.
Tesis de Inversión
Accendra Health, Inc. (ACH) presents a speculative investment opportunity given its current financial challenges, as reflected in its negative P/E ratio of -0.01 and a profit margin of -20.0%. However, the company's strategic focus on healthcare solutions, coupled with its established presence in the medical distribution market, offers potential for future growth. Key value drivers include optimizing operational efficiency, expanding its Patient Direct segment, and leveraging its comprehensive suite of products and services. Upcoming catalysts include potential improvements in profitability through cost reduction initiatives and strategic partnerships. Successful execution of these strategies could drive long-term value creation, although significant risks remain.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.17 billion, indicating a relatively small-cap company.
- Negative P/E ratio of -0.01, reflecting current losses and potential undervaluation.
- Gross margin of 26.1%, suggesting moderate profitability on sales before operating expenses.
- Beta of 1.34, indicating higher volatility compared to the overall market.
- No dividend yield, meaning the company is not currently returning capital to shareholders through dividends.
Competidores y Pares
Fortalezas
- Comprehensive product and service offerings.
- Established relationships with healthcare providers.
- Presence in both Products & Healthcare Services and Patient Direct segments.
- Long operating history and industry experience.
Debilidades
- Negative profit margin and P/E ratio.
- High beta indicating higher volatility.
- Dependence on third-party distributors.
- Intense competition in the medical distribution market.
Catalizadores
- Ongoing: Cost reduction initiatives to improve profitability.
- Upcoming: Potential strategic partnerships to expand product offerings.
- Upcoming: Launch of new proprietary products.
- Ongoing: Expansion of the Patient Direct segment.
Riesgos
- Ongoing: Intense competition in the medical distribution market.
- Potential: Economic downturn affecting healthcare spending.
- Potential: Changes in healthcare regulations and reimbursement policies.
- Potential: Supply chain disruptions.
- Ongoing: Negative profit margin and P/E ratio.
Oportunidades de crecimiento
- Expansion of Patient Direct Segment: The Patient Direct segment offers significant growth potential as the demand for in-home healthcare solutions increases. By expanding its product offerings and enhancing its delivery capabilities, Accendra Health can capitalize on the growing trend of remote patient monitoring and telehealth. This could involve strategic partnerships with telehealth providers and investments in logistics infrastructure to ensure timely and efficient delivery of medical equipment and supplies. The market for home healthcare is projected to reach $367 billion by 2027, presenting a substantial opportunity for ACH.
- Strategic Partnerships and Acquisitions: Accendra Health can pursue strategic partnerships and acquisitions to expand its product portfolio and geographic reach. Collaborating with innovative healthcare technology companies can enhance its service offerings and attract new customers. Acquiring smaller players in the medical distribution market can consolidate its market position and create synergies. These initiatives can drive revenue growth and improve operational efficiency. The timeline for these partnerships and acquisitions is ongoing, with potential deals expected to be announced in the next 12-24 months.
- Optimization of Supply Chain Management: Accendra Health can further optimize its supply chain management to reduce costs and improve efficiency. Implementing advanced analytics and inventory management systems can help streamline operations and minimize waste. Negotiating favorable terms with suppliers and leveraging its scale to achieve economies of scale can also contribute to cost savings. These efforts can improve the company's gross margin and enhance its competitiveness. The timeline for these improvements is ongoing, with incremental benefits expected to be realized over the next 12-36 months.
- Focus on Proprietary Products: Developing and promoting its proprietary products can differentiate Accendra Health from its competitors and improve its profitability. By investing in research and development, the company can create innovative medical supplies and equipment that meet the evolving needs of healthcare providers and patients. These proprietary products can command higher margins and strengthen customer loyalty. The timeline for launching new proprietary products is expected to be within the next 12-24 months.
- Expansion into New Geographies: Accendra Health can expand its operations into new geographies to tap into underserved markets and diversify its revenue streams. This could involve entering emerging markets with growing healthcare spending or expanding its presence in existing markets through strategic partnerships and acquisitions. By diversifying its geographic footprint, the company can reduce its reliance on any single market and mitigate risks. The timeline for geographic expansion is expected to be within the next 24-48 months.
Oportunidades
- Expansion of Patient Direct segment.
- Strategic partnerships and acquisitions.
- Optimization of supply chain management.
- Development of proprietary products.
Amenazas
- Economic downturn affecting healthcare spending.
- Changes in healthcare regulations and reimbursement policies.
- Increased competition from larger players.
- Supply chain disruptions.
Ventajas competitivas
- Established relationships with healthcare providers and suppliers.
- Comprehensive product portfolio spanning medical supplies and equipment.
- Value-added services such as supplier management and analytics.
- Proprietary products that differentiate the company from competitors.
Acerca de ACH
Founded in 1882 and based in Glen Allen, Virginia, Accendra Health, Inc. (ACH), formerly known as Owens & Minor, Inc., has evolved into a global healthcare solutions company. The company operates through two primary segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment provides a wide array of medical and surgical supplies, including both branded and proprietary products, to healthcare providers and manufacturers. Additionally, this segment offers value-added services such as supplier management, analytics, inventory management, and clinical supply management. These services are designed to optimize supply chain efficiency and reduce costs for healthcare providers. The Patient Direct segment focuses on delivering products and services directly to patients for in-home care. This includes solutions for diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. The segment also supplies a range of home medical equipment and patient care products, such as ostomy, wound care, urology, and incontinence supplies. ACH serves a diverse customer base, including multi-facility networks of healthcare providers, independent hospitals, surgery centers, and physicians' practices, both directly and indirectly through third-party distributors. The company changed its name to Accendra Health, Inc. in December 2025, signaling a renewed focus on its core mission of providing comprehensive healthcare solutions.
Qué hacen
- Provides medical and surgical supplies to healthcare providers.
- Offers products and services for in-home care and delivery.
- Supplies equipment for diabetes treatment, respiratory therapy, and sleep apnea.
- Offers supplier management and inventory management services.
- Provides analytics and clinical supply management solutions.
- Delivers patient care products, including ostomy and wound care supplies.
- Offers outsourced logistics and marketing solutions to suppliers.
Modelo de Negocio
- Sells medical supplies and equipment to healthcare providers and patients.
- Generates revenue through value-added services such as supplier management and analytics.
- Provides logistics and marketing solutions to suppliers.
- Focuses on both branded and proprietary products to maximize profitability.
Contexto de la Industria
Accendra Health, Inc. operates within the medical distribution industry, a sector characterized by increasing demand for efficient supply chain solutions and patient-centric care. The market is competitive, with companies vying to provide comprehensive product portfolios and value-added services to healthcare providers and patients. Key trends include the growing adoption of telehealth and remote patient monitoring, which is driving demand for home medical equipment and supplies. Accendra Health competes with companies like ACRS, ALLO, BIOA, CABA, and CGC, all striving to capture market share in this evolving landscape.
Clientes Clave
- Multi-facility networks of healthcare providers.
- Independent hospitals and surgery centers.
- Physicians' practices.
- Patients requiring in-home care.
Finanzas
Gráfico e información
Precio de la acción de Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH): $2.27 (+0.06, +2.71%)
Últimas noticias
-
Earnings Scheduled For February 19, 2026
benzinga · 19 feb 2026
-
'Muskonomy' shakeup: SpaceX valuation approaches Tesla's after merger with xAI
CNBC · 4 feb 2026
-
Nvidia, OpenAI appear stalled on their mega deal. But the AI giants still need each other
CNBC · 3 feb 2026
-
AWC Partners with Marriott International to Develop The Ritz Carlton at Aquatique in Pattaya and Marriott Hotel in Koh Samui, Reinforcing a Long-Standing Strategic Partnership in Sustainable...
Business Insider · 3 feb 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ACH.
Objetivos de Precios
Objetivo de consenso: $4.00
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ACH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
Earnings Scheduled For February 19, 2026
'Muskonomy' shakeup: SpaceX valuation approaches Tesla's after merger with xAI
Nvidia, OpenAI appear stalled on their mega deal. But the AI giants still need each other
AWC Partners with Marriott International to Develop The Ritz Carlton at Aquatique in Pattaya and Marriott Hotel in Koh Samui, Reinforcing a Long-Standing Strategic Partnership in Sustainable...
Último análisis de Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company
Preguntas Comunes Sobre ACH
¿Cuáles son los factores clave para evaluar ACH?
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Los analistas apuntan a $4.00 (+76% desde $2.27). Fortaleza clave: Comprehensive product and service offerings.. Riesgo principal a monitorear: Ongoing: Intense competition in the medical distribution market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ACH?
ACH actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ACH?
Los precios de ACH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ACH?
Los analistas han establecido un precio objetivo de consenso de $4.00 para ACH, representando un potencial alcista del 76% desde el precio actual de $2.27. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ACH?
Las categorías de riesgo para ACH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the medical distribution market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ACH?
La relación P/E para ACH compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ACH sobrevalorada o infravalorada?
Determinar si Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Objetivo de analistas $4.00 (+76% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ACH?
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data based on limited information.
- Future performance is subject to market conditions and company execution.